Basic information Safety Supplier Related

6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE

Basic information Safety Supplier Related

6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE Basic information

Product Name:
6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE
Synonyms:
  • 6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE
  • 6,8-Dibromoimidazol[1,2-a]pyrazine
  • IMidazo[1,2-a]pyrazine, 6,8-dibroMo-
  • 8-dibroMoiMidazo[1
  • 6,8-Dibromoimidazo[1,2-a]pyrazine>
  • 6,8-Dibromoimidazo[1,2-a]pyrazine,95%
  • 6,8-Dibromo imidazole [1,2-A] pyrazine
CAS:
63744-22-9
MF:
C6H3Br2N3
MW:
276.92
EINECS:
811-059-4
Product Categories:
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • CHIRAL CHEMICALS
  • Heterocycles series
Mol File:
63744-22-9.mol
More
Less

6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE Chemical Properties

Melting point:
165.0 to 169.0 °C
Density 
2.35±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
powder to crystal
pka
-0.36±0.30(Predicted)
color 
White to Amber
Water Solubility 
Slightly soluble in water.
InChI
InChI=1S/C6H3Br2N3/c7-4-3-11-2-1-9-6(11)5(8)10-4/h1-3H
InChIKey
UQCZZGIPIMJBCL-UHFFFAOYSA-N
SMILES
C12=NC=CN1C=C(Br)N=C2Br
More
Less

Safety Information

HS Code 
2933998090
More
Less

6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE Usage And Synthesis

Uses

6,8-Dibromoimidazo[1,2-a]pyrazine is a imidazopyrazine derivative with uterine-relaxing, antibronchospastic, and cardiac-stimulating properties. 6,8-Dibromoimidazo[1,2-a]pyrazine also displays theophylline-like properties.

Uses

It is an Intermediate in organic syntheses.

Synthesis

7252-83-7

24241-18-7

63744-22-9

1. 3,5-dibromopyrazin-2-amine (1018 g, 4.03 mol) was dissolved in water (10 kg) at room temperature. 2. 2-bromo-1,1-dimethoxyethane (1.79 kg, 4.14 mol) was added to the above solution and mixed with stirring. 3. The reaction mixture was heated to reflux and held for 2 hours. 4. After the reaction was complete, water (15.3 kg) and sodium bicarbonate (744 g) were added to the reaction solution and stirring was continued for 15 minutes. 5. The reaction mixture was filtered and the solid product was collected. 6. 6. After drying, 6,8-dibromoimidazo[1,2-A]pyrazine (1106 g, 3.99 mmol, 99% yield) was obtained as a brown solid. 7. The structure of the product was confirmed by 1H-NMR (400 MHz, DMSO-d6): δ 7.90 (s, 1H), 8.23 (s, 1H), 9.02 (s, 1H).

References

[1] Patent: US2012/59162, 2012, A1. Location in patent: Page/Page column 53-54
[2] Patent: WO2005/85252, 2005, A1. Location in patent: Page/Page column 37-38; 40-41
[3] Journal of Medicinal Chemistry, 2015, vol. 58, # 1, p. 512 - 516
[4] Patent: WO2016/209895, 2016, A1. Location in patent: Paragraph 15; 16

6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINESupplier

Nanjing Jubai Biomedical Technology Co., Ltd. Gold
Tel
13585203734
Email
info@jbzml.com
Tongchuang Pharma(Suzhou). Co., Ltd. Gold
Tel
0512-63263366 18912765016
Email
tongtf110@sina.com
Shanghai Dalikang Medical Technology Co., LTD Gold
Tel
18658316824
Email
2587687349@qq.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd Gold
Tel
18270980682
Email
mlcheng@sunwaypharm.cn
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com